Law firms Dealwatch: Baker & McKenzie and Ropes & Gray lead on Merck’s $8.4bn superbug takeover Legal Business · 9 December 2014 · 2 min read Corporate and M&A Deal watch US firms Baker McKenzie Ropes & Gray One of the world’s biggest pharma groups, New Jersey-based Merck, instructed an all-female partner team from Baker & McKenzie to help it execute its $8.4bn takeover of Cubist Pharmaceuticals.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryTrading Places: Simpson Thacher builds capital solutions with new Dallas co-head as Latham adds capital markets vice chairLaw firmsWill Lewallen27 Jul 2026Baker McKenzie matches Macfarlanes with £150k NQ salary hike as Pallas and Katten also bump City payLaw firmsTom Cox20 Jul 2026Revolving Doors: Simpson Thacher builds London fund finance practice, while Latham bolsters Brussels antitrustLaw firmsNews Editor17 Jul 2026US quartet lead on Grant Thornton’s landmark $5bn CBIZ acquisitionLaw firmsTheresa Hargreaves30 Jul 2026Freshfields and Slaughters set to share £40m-plus fees on EQT-Intertek dealLaw firmsTom Cox30 Jul 2026Macfarlanes closes in on £400m as PEP stays flatLaw firmsTom Cox29 Jul 2026‘There’s a lot of money in Chicago’ – the city’s top lawyers on what’s driving business in the MidwestLaw firmsAlex Ryan13 Jan 2025Legal 500 US: Latham tops the charts in new US rankingsLegal 500 dataBarnaby Merrill28 Jun 2024Dealwatch: Global 100 advisers take centre stage on BlackRock-GIP $12.5bn mega dealLaw firmsAlex Ryan15 Jan 2024